Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety/Efficacy of Intranasally-Administered Bioactive Factors Produced by Autologous M2 Macrophages in Patients With Organic Brain Syndrome

NCT02957123 is registered in ClinicalTrials.gov with Russian Academy of Medical Sciences as lead sponsor.

NCT NCT02957123
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02957123 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety/Efficacy of Intranasally-Administered Bioactive Factors Produced by Autologous M2 Macrophages in Patients With Organic Brain Syndrome
Lead sponsor
Russian Academy of Medical Sciences
Phase
Phase 1/2
Overall status
Completed
Start date
March 31, 2016
Completion date
September 30, 2020
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain ischemia, delirium, dementia, amnestic, cognitive disorders, encephalopathy, ischemic, encephalopathy, post-traumatic, chronic, mental disorder, organic, neurocognitive disorders, nonpsychotic organic brain syndrome, organic brain syndrome, nonpsychotic, organic mental disorder